The Department of Ophthalmic Research is committed to improving the understanding of the molecular and cellular basis of vision loss and exploiting this knowledge to develop targeted therapeutics.More About Us
The Jonathan Sears lab investigates new therapies to treat retinopathy of prematurity, a form of infant blindness.Learn More
The Steven Wilson lab investigates the molecular and cellular changes that affect corneal function and health.Learn More
The Fatema Ghasia lab studies abnormal neural circuits in visual deficits to help diagnose abnormal eye motions.Learn More
Researchers study Brillouin spectroscopy to provide additional treatment options for patients with keratoconus.
Generating a virtual copy of the eyes to create personalized surgical plans will help lower operative risks and improve outcomes for patients with corneal disease.
Researcher aims to discover the function TULP1 gene plays in the blinding disease, retinitis pigmentosa.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Ophthalmic Research.View Careers